Prestige Consumer Healthcare (PBH) Shares Outstanding (Weighted Average) (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Shares Outstanding (Weighted Average) of $48.8 million in Q4 2025, down 0.93% quarter-over-quarter from $49.2 million in Q3 2025, and down 1.63% on a YoY basis from $49.6 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Shares Outstanding (Weighted Average) (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $48.8 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Weighted Average) fell 1.63% year-over-year to $48.8 million; the TTM figure through Dec 2025 stood at $48.8 million (down 1.63% YoY), while the FY2025 annual figure was $49.7 million, changed 0.12% from the prior year.
- Shares Outstanding (Weighted Average) was $48.8 million for Q4 2025 at Prestige Consumer Healthcare, down from $49.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $50.3 million in Q2 2022 to a low of $48.8 million in Q4 2025.
- Historically, Shares Outstanding (Weighted Average) has averaged $49.8 million across 5 years, with a median of $49.8 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) gained 0.25% in 2022, then decreased 1.63% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $50.2 million in 2021, then fell by 1.06% to $49.7 million in 2022, then climbed by 0.08% to $49.7 million in 2023, then fell by 0.27% to $49.6 million in 2024, then declined by 1.63% to $48.8 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $48.8 million (Q4 2025), $49.2 million (Q3 2025), and $49.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 48.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.79 Mn |
| Sep 30, 2025 | 49.25 Mn |
| Jun 30, 2025 | 49.48 Mn |
| Mar 31, 2025 | 49.70 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Sep 30, 2024 | 49.65 Mn |
| Jun 30, 2024 | 49.89 Mn |
| Mar 31, 2024 | 49.76 Mn |
| Dec 31, 2023 | 49.73 Mn |
| Sep 30, 2023 | 49.69 Mn |
| Jun 30, 2023 | 49.77 Mn |
| Mar 31, 2023 | 49.89 Mn |
| Dec 31, 2022 | 49.69 Mn |
| Sep 30, 2022 | 50.03 Mn |
| Jun 30, 2022 | 50.26 Mn |
| Mar 31, 2022 | 50.26 Mn |
| Dec 31, 2021 | 50.23 Mn |
| Sep 30, 2021 | 50.19 Mn |
| Jun 30, 2021 | 50.14 Mn |
| Mar 31, 2021 | 50.21 Mn |